NHSE - NWL Provision of Covid-19 Vaccination Services

CPV: Miscellaneous health services

Procedure method

Award procedure without prior publication of a call for competition

Legal basis

CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)

Procurement category

Services

Notice status

Awarded without competition

Procurement threshold

Unspecified in notice

Regulatory regime

Standard

Commercial structure

Stand-alone contract (no framework)

Competition type

Direct award (no call for competition)

GPA / WTO covered

Yes (GPA)

Recurring procurement

Unspecified in notice

First published

9 Apr 2025, 13:16 BST

Last source update

9 Apr 2025, 13:16 BST

Authority reference

PRJ2170

FTS notice number

2025/S 000-013957

Classification (CPV)

Miscellaneous health services

Delivery area

London (UKI)

Official registry OCID

ocds-h6vhtk-04ffa1 Find a Tender

Why no open competition

The procurement falls outside the scope of application of the directive

Published justification

This contract has been awarded under the urgent circumstances provision of the Provider Selection Regime (PSR). This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.

This an incumbent provider within the NWL footprint, having taken part in previous campaigns. A delay in national confirmation of funding created an unrealistic timeframe, in which a full procurement process would have left gaps in the provision of vaccines in the upcoming Spring campaign for large numbers of eligible individuals and/or groups. Discussion has taken place with all London ICB Programme Leads and it has been agreed that due to the serious time constraints and ensuring readiness for Spring, a direct award of 12 months to incumbent providers is essential. In addition, there is significant concern on the extent of reduction in Access and Inequalities funding, and with no surge budget this year, that providers will not come forward to support any shorter contract period as it is not financially viable for them. It is recommended that regional approval is provided to issue direct award contracts to existing incumbent providers to enable the commissioning of outreach services for 2025/26.

Publisher note: This contract has been awarded under the urgent circumstances provision of the Provider Selection Regime (PSR). This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. This an incumbent provider within the NWL footprint, having taken part in previous campaigns. A delay in national confirmation of funding created an unrealistic timeframe, in which a full procurement process would have left gaps in the provision of vaccines in the upcoming Spring campaign for large numbers of eligible individuals and/or groups. Discussion has taken place with all London ICB Programme Leads and it has been agreed that due to the serious time constraints and ensuring readiness for Spring, a direct award of 12 months to incumbent providers is essential. In addition, there is significant concern on the extent of reduction in Access and Inequalities funding, and with no surge budget this year, that providers will not come forward to support any shorter contract period as it is not financially viable for them. It is recommended that regional approval is provided to issue direct award contracts to existing incumbent providers to enable the commissioning of outreach services for 2025/26. Award decision makers: Following a national CEG decision, the London Regional Executive team approved the request for an Outreach Service, Direct Award (12 months) to incumbent providers. - Regional Director of Finance, NHSE London - Regional Director of Commissioning, NHSE London - Director of Commissioning Finance, NHSE London Approval was also given by: - Operational Director - Covid-19 and Influenza Vaccination Programmes, NHSE London - Assistant Director of Delivery, NHSE London - Vaccine Programme Lead, NHSE London There were no conflicts of interest identified in the decision making process.

• CHELSEA AND WESTMINSTER HOSPITAL NHS FOUNDATION TRUSTAwarded supplierGB-NHS: RQM London, London

No document links were published on the notice.